blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1446381

EP1446381 - ANTHRANILIC ACID AMIDES AND PHARMACEUTICAL USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.2011
Database last updated on 11.09.2024
Most recent event   Tooltip18.11.2011Lapse of the patent in a contracting state
New state(s): CZ, SK
published on 21.12.2011  [2011/51]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4002 Basel / CH
[2010/45]
Former [2010/31]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  SK  TR 
Novartis AG
Lichtstrasse 35
4002 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2009/43]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT 
Novartis AG
Lichtstrasse 35
4002 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2004/34]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT 
Novartis AG
Lichtstrasse 35
4002 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1235 Vienna / AT
Inventor(s)01 / BOLD, Guido
Bleumatthöhe 16
CH-5073 Gipf-Oberfrick / CH
02 / FURET, Pascal
24, rue du Riegelsbourg
F-68800 Thann / FR
03 / MANLEY, Paul, William
Bruggweg 12
CH-4144 Arlesheim / CH
 [2004/34]
Representative(s)de Weerd, Petrus G.W., et al
Novartis International AG
Corporate Intellectual Property
4002 Basel / CH
[N/P]
Former [2005/12]de Weerd, Petrus G.W., et al
Novartis International AG Corporate Intellectual Property
4002 Basel / CH
Former [2004/34]Grubb, Philip William
Novartis AG, Corporate Intellectual Property
4002 Basel / CH
Application number, filing date02779536.807.11.2002
[2004/34]
WO2002EP12445
Priority number, dateGB2001002690108.11.2001         Original published format: GB 0126901
GB2002001291705.06.2002         Original published format: GB 0212917
[2004/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03040101
Date:15.05.2003
Language:EN
[2003/20]
Type: A1 Application with search report 
No.:EP1446381
Date:18.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 15.05.2003 takes the place of the publication of the European patent application.
[2004/34]
Type: B1 Patent specification 
No.:EP1446381
Date:05.01.2011
Language:EN
[2011/01]
Search report(s)International search report - published on:EP15.05.2003
ClassificationIPC:C07D213/38, C07D213/89, C07C237/40, A61K31/44, A61K31/165, A61P35/00
[2004/34]
CPC:
C07C237/40 (EP,KR,US); C07D213/38 (EP,KR,US); A61K31/44 (KR);
A61P11/06 (EP); A61P15/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P27/00 (EP); A61P27/06 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P9/10 (EP); C07D213/89 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/34]
Extension statesAL08.06.2004
LT08.06.2004
LV08.06.2004
MK08.06.2004
RO08.06.2004
SI08.06.2004
TitleGerman:ANTHRANILSÄUREAMIDE UND IHRE PHARMAZEUTISCHE VERWENDUNG[2004/34]
English:ANTHRANILIC ACID AMIDES AND PHARMACEUTICAL USE THEREOF[2004/34]
French:AMIDES D'ACIDE ANTHRANILIQUE ET UTILISATIONS PHARMACEUTIQUES[2004/34]
Entry into regional phase08.06.2004National basic fee paid 
08.06.2004Designation fee(s) paid 
08.06.2004Examination fee paid 
Examination procedure29.04.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.06.2004Examination requested  [2004/34]
27.10.2004Despatch of a communication from the examining division (Time limit: M04)
28.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.12.2009Reply to a communication from the examining division
12.02.2010Despatch of a communication from the examining division (Time limit: M02)
30.03.2010Reply to a communication from the examining division
06.07.2010Communication of intention to grant the patent
26.10.2010Fee for grant paid
26.10.2010Fee for publishing/printing paid
Divisional application(s)EP10180423.5  / EP2269988
Opposition(s)06.10.2011No opposition filed within time limit [2011/50]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
23.12.2009Request for further processing filed
23.12.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
30.11.2004Renewal fee patent year 03
30.11.2005Renewal fee patent year 04
30.11.2006Renewal fee patent year 05
15.11.2007Renewal fee patent year 06
31.03.2008Renewal fee patent year 07
11.11.2009Renewal fee patent year 08
12.11.2010Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
SE05.01.2011
SK05.01.2011
BG05.04.2011
[2011/51]
Former [2011/47]CY05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
SE05.01.2011
BG05.04.2011
Former [2011/37]CY05.01.2011
FI05.01.2011
SE05.01.2011
BG05.04.2011
Cited inInternational search[XD]WO0027820  (NOVARTIS AG [CH], et al) [XD] 1,9,10,12,13* claims 1-17; table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.